World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research

Grants

Funding Acknowledgements

A.F. has nothing to disclose. N.R. has nothing to disclose. A.F.V. has nothing to disclose. P.V. has a consultancy for Roche Diagnostics International. L.C.G. is an academic associate with Quest Diagnostics, and is a non-remunerated board member of WERF. T.M.D'H. receives research and travel grants from Ferring Pharmaceuticals and Merck Serono Merck, Besins, and Pharmaplex, and consultancy fees from Astellas, Bayer Pharma, Proteomika, Roche Diagnostics International, and Teva. L.H. has been remunerated by WERF for project management. G.D.A. is the CEO of Advanced Reproductive Care, receives research funds from Auxogyn, has a consultancy with Bayer Pharma, Glycotope, and Ziva, and is a nonremunerated board member of WERF. C.M.B. received research grants from Bayer Pharma and consultancy fees from Roche Diagnostics International. S.A.M. is a non-remunerated board member of WERF. K.T.Z. is a member of scientific advisory boards of Abbvie, Bayer Pharma, and Roche Diagnostics International and has received honoraria for lectures from Bayer Pharma. The WERF EPHect Working Group (not listed in the author list): C.A. is on the Actavis advisory board, Bayer Pharma AG advisory board, and is a Johnson and Johnson speaker; K.C. is employed by AbbVie and holds stock in this company; T.F. is employed by Bayer Pharma AG; L.K. receives speaker fees from Bayer Pharma AG and consultancy fees from Roche Diagnostics International Ltd; K.M. is employed by Bayer Pharma AG; A.N. receives consulting fees from Merck Serono and MSD; C.A.P. is a consultant for Bayer Pharma AG and is a non-remunerated board member of WERF; S.P.R. receives consultancy fees from Roche Diagnostics International Ltd, Gedeon-Richter, and Ethicon, and honorarium for lectures from Jenapharm; J.R. is employed by Roche Diagnostics International Ltd; S.R. is employed by Bayer Pharma AG; E. S. receives honoraria from Ethicon and Gedeon-Richter for providing training to healthcare professionals; U.-H.W.-T. is employed by Roche Diagnostics International Ltd; P.P.Y. is a consultant for Lumenis; K.V. receives honoraria and travel expenses for lectures from Bayer Pharma AG. R.A has nothing to disclose. M.A.B.D. has nothing to disclose. G.M. Buck Louis has nothing to disclose. C.C.-J. has nothing to disclose. A.T.F. has nothing to disclose. I.F. has nothing to disclose. A.F. has nothing to disclose. I.F. has nothing to disclose. M.G. has nothing to disclose. P. G. has nothing to disclose. S.-W.G. has nothing to disclose. T.H. has nothing to disclose. D.H. has nothing to disclose. A.W.H. has nothing to disclose. M.L.H. has nothing to disclose. M.G.I. has nothing to disclose. M.R.L. has nothing to disclose. S.S.T. has nothing to disclose. S.M. has nothing to disclose. G.W.M. has nothing to disclose. M.N. has nothing to disclose. K.G.O. has nothing to disclose. P.A.R. has nothing to disclose. L.R. is a non-remunerated board member of WERF. A. S. has nothing to disclose. T. Seckin has nothing to disclose. P. Stratton has nothing to disclose. K.L.S.-T. has nothing to disclose. P.Y. has nothing to disclose. This work was funded by the World Endometriosis Research Foundation through grants from AbbVie, Bayer Pharma, and Roche Diagnostics International. K.T.Z. is supported by a Wellcome Trust Career Development Fellowship (grant no. WT085235/Z/08/Z); N.R. is supported by an Medical Research Council grant (grant no. MR/K011480/1); S.A.M. and A.F.V. are supported, in part, by the J. Willard and Alice S. Marriott Foundation contribution to the Boston Center for Endometriosis, and S.A.M. by an NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development grant (grant no. HD57210); C.M.B. is supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres Scheme; I. F. is supported by the Puerto Rico Science and Technology Trust (grant no. 2013-000032); M.G.I. holds a scholarship from the Ernst Schering Foundation and an Elsa Neumann stipend from Landes Berlin; K. V. is supported by an NIHR Academic Clinical Lecturer Award; A.W.H. is supported by grants from the Chief Scientist Office Scotland, Wellbeing of Women, and Health Technology Assessment; K.G.O. is supported by a grant from the Endometriosis Association; and L.C.G. is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development Specialized Cooperative Centers Program in Reproduction and Infertility Research (grant no. vU54HD 055764).